SCHEDULE OF CONSUMMATION OF THE BUSINESS COMBINATION (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
shares
| |
| Recapitalization | |
| PowerUp Class A common stock, outstanding prior to the Reverse Recapitalization | 7,765,144 |
| Less: Redemption of PowerUp Class A common stock | (507,631) |
| Class A common stock of PowerUp | 7,257,513 |
| PowerUp Class B common stock, outstanding prior to the Reverse Recapitalization | |
| Reverse Recapitalization Class A common stock, before giving effect to the 1-for-40 reverse split | 7,257,513 |
| Reverse Recapitalization Class A common stock, after giving effect to the 1-for-40 reverse split | 181,438 |
| Issuance of shares related working capital agreements | 93,750 |
| Aspire Biopharma, Inc. Shares | 875,000 |
| Common Stock immediately after the Reverse Recapitalization, after giving effect to the 1-for-40 reverse split | 1,150,188 |